Overview A Long-Term Study in Schizophrenia Status: Terminated Trial end date: 2012-10-01 Target enrollment: Participant gender: Summary The purpose of this study is to evaluate the long-term safety of pomaglumetad methionil in participants with schizophrenia. Phase: Phase 3 Details Lead Sponsor: Eli Lilly and Company